Cita APA

Perez-Ruiz, E. (., Melero, I. (., Kopecka, J. (., Sarmento-Ribeiro, A. (. B., García-Aranda, M. (., & De-las-Rivas, J. (. (2020). Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.

Citación estilo Chicago

Perez-Ruiz, E. (Elisabeth)|||/items/d83c356b-f521-479f-83df-13785e169cc1, I. (Ignacio)|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e Melero, J. (Joanna)|||/items/f26ff137-211a-4a95-b95b-81ceca000f68 Kopecka, A.B. (Ana Bela)|||/items/3f97b344-cb6d-4660-b68a-58097bedc681 Sarmento-Ribeiro, M. (Marilina)|||/items/7034c780-0605-465c-83e3-684285edb088 García-Aranda, y J. (Javier)|||/items/b5d1fa8a-1dd5-4d29-8fd4-804b7432de5f De-las-Rivas. Cancer Immunotherapy Resistance Based On Immune Checkpoints Inhibitors: Targets, Biomarkers, and Remedies. 2020.

Cita MLA

Perez-Ruiz, E. (Elisabeth)|||/items/d83c356b-f521-479f-83df-13785e169cc1, et al. Cancer Immunotherapy Resistance Based On Immune Checkpoints Inhibitors: Targets, Biomarkers, and Remedies. 2020.